Zobrazeno 1 - 10
of 2 305
pro vyhledávání: '"PRRT"'
Autor:
Baharak Behmanesh, Akbar Abdi-Saray, Mohammad Reza Deevband, Mahasti Amoui, Hamid Reza Haghighatkhah
Publikováno v:
Journal of Biomedical Physics and Engineering, Vol 14, Iss 5, Pp 423-434 (2024)
Background: Radiomics is the computation of quantitative image features extracted from medical imaging modalities to help clinical decision support systems, which could ultimately meliorate personalized management based on individual characteristics.
Externí odkaz:
https://doaj.org/article/9f98e24b02c84033971942b103c0d105
Autor:
Leandra Piscopo, Emilia Zampella, Fabio Volpe, Valeria Gaudieri, Carmela Nappi, Erica Di Donna, Stefania Clemente, Antonio Varallo, Mariano Scaglione, Alberto Cuocolo, Michele Klain
Publikováno v:
Current Oncology, Vol 31, Iss 9, Pp 5617-5629 (2024)
The aim of the present study was to evaluate the safety and efficacy of radionuclide therapy with [177Lu]Lu-DOTA-TATE according to our single center experience at the University of Naples Federico II. For the present analysis, we considered 21 patien
Externí odkaz:
https://doaj.org/article/a2dee3d0e61b43c9b6b706b9d0bab36d
Publikováno v:
EJNMMI Physics, Vol 11, Iss 1, Pp 1-13 (2024)
Abstract Background Dosimetry after [177Lu]Lu-DOTA-TATE therapy can be demanding for both patients and the clinical service due to the need for imaging at several time points. In this work we compare three methods of single time point (STP) kidney do
Externí odkaz:
https://doaj.org/article/c4732775f4ab4c1d93ad07ed8e027d00
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Virginie Jacques, Lawrence Dierickx, Jean Sebastien Texier, Severine Brillouet, Frederic Courbon, Rosine Guimbaud, Lavinia Vija, Frederique Savagner
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
Background177Lu-oxodotreotide peptide receptor therapy (LuPRRT) is an efficient treatment for midgut neuroendocrine tumors (NETs) of variable radiological response. Several clinical, biological, and imaging parameters may be used to establish a relat
Externí odkaz:
https://doaj.org/article/c4f035a40e2341ee8b5185bf62dc846b
Autor:
Ryosuke Umino, Satoshi Nara, Noritoshi Kobayashi, Takahiro Mizui, Takeshi Takamoto, Daisuke Ban, Minoru Esaki, Nobuyoshi Hiraoka, Kazuaki Shimada
Publikováno v:
Surgical Case Reports, Vol 10, Iss 1, Pp 1-11 (2024)
Abstract Background Peptide receptor radionuclide therapy (PRRT) serves as a novel and effective treatment option for somatostatin receptor-positive unresectable liver metastases of pancreatic neuroendocrine tumors (PNETs). However, there are few rep
Externí odkaz:
https://doaj.org/article/a149bdf0a8d347cbb5a61a3901b3426f
Publikováno v:
EJNMMI Research, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Background Peptide receptor radionuclide therapy is effective in treating neuroendocrine tumours, but treatment may be limited by kidney and bone marrow toxicity. In this work, the absorbed dose burden to the bone marrow was estimated using
Externí odkaz:
https://doaj.org/article/9068cb39c96b4a4da6cf042aa1dca40e
Publikováno v:
Pharmaceuticals, Vol 17, Iss 10, p 1314 (2024)
The poor prognosis of pancreatic cancer requires novel treatment options. This review examines the evolution of radiopharmaceuticals in the treatment of pancreatic cancer. Established strategies such as peptide receptor radionuclide therapy (PRRT) of
Externí odkaz:
https://doaj.org/article/63d3333ebfc2460b993eca4421671594
Autor:
Riccardo Laudicella, Fabio Minutoli, Simona Russo, Massimiliano Siracusa, Michelangelo Bambaci, Benedetta Pagano, Sergio Baldari
Publikováno v:
Urology Case Reports, Vol 54, Iss , Pp 102750- (2024)
Radioligand therapy with [177Lu]Lu-PSMA is a theranostic approach for heavily treated mCRPC patients with positive PSMA PET in the absence of relevant PSMA-negative metastases assessed through CT, MRI, bone scan or FDG PET. In this case, we described
Externí odkaz:
https://doaj.org/article/7fa847813f2e4d799e63a1533c22c982
Autor:
Egesta Lopci, Federica Matteucci
Publikováno v:
Frontiers in Nuclear Medicine, Vol 4 (2024)
Externí odkaz:
https://doaj.org/article/572c908605134f29bd56f03d204def24